Gilead Owed $68M In Counterfeit Case, Magistrate Judge Says
By Elliot Weld · July 1, 2026, 8:17 PM EDT
A New York federal magistrate judge has recommended awarding $68 million to biopharmaceutical company Gilead Sciences Inc. from a group of companies it accused of producing counterfeit HIV drugs that never...
To view the full article, register now.